Skip to main content
. 2019 Oct 22;9:1116. doi: 10.3389/fonc.2019.01116

Figure 1.

Figure 1

Kaplan-Meier curve of PFS (A) of all patients (n = 104); (B) of patients age ≥ 49.5 years old or <49.5 years old; (C) of patients with or without baseline adrenal gland metastasis; (D) of patients diagnosed with adenocarcinoma or non-adenocarcinoma; (E) of patients with or without BBM; (F) of patients with or without baseline adrenal gland metastasis in non-BBM group; (G) of patients administered with crizotinib as first-line therapy or second or later line in non-BBM group.